Leo Cendrowicz[email protected]Industry NewsNuclear medicine copes with upheaval in pandemicAt one point this year, it looked like Europe's entire nuclear medicine sector would have to be put on hold, said Antonis Kalemis, PhD, president of Nuclear Medicine Europe. When COVID-19 began spreading rapidly, industry felt huge anxiety as the lockdown measures escalated, but it has pulled together and survived.December 14, 2020Clinical NewsAIPES changes name to Nuclear Medicine EuropeThe Association of Imaging Producers & Equipment Suppliers (AIPES) has changed its name to Nuclear Medicine Europe (NM-EU). The new name reflects the group's aims to represent industry's interests more effectively and improve its brand identity. The first president of NM-EU is Antonis Kalemis, PhD.May 22, 2019RegulatoryWhy patient communication's central to better cancer careBRUSSELS - Effective communication among radiologists, referring physicians, and patients is essential to advance care, Lieve Wierinck, a Belgian Member of the European Parliament and cancer survivor, told attendees at a special seminar held on 6 June.June 7, 2018Molecular ImagingHealth warning: Experts spell out Brexit risksBRUSSELS - Brexit could be devastating for the nuclear medicine sector, disrupting the free flow of radioisotopes and movement of medical imaging staff between the U.K. and the rest of the European Union, medical experts and politicians warned in Brussels on 23 May.May 23, 2018Molecular ImagingHow do we measure molecular imaging's cost-effectiveness?Assessing the cost-effectiveness of molecular imaging is more about economics than medicine, according to David W. Lee, PhD, of GE Healthcare. The real benefits for society depend on the cost of the technology and the value people place on their health, he said at last week's symposium in Brussels.October 2, 2016Clinical NewsManiawski: We must sell molecular imaging betterMolecular imaging can drive personalized medicine and revolutionize healthcare, but unless the nuclear medicine sector improves its communications and outreach, it could be years before we see the benefits, Piotr Maniawski of Philips Healthcare told a symposium in Brussels on Wednesday.September 29, 2016Organized Radiology IssuesESR makes reform plea to new EU leadersBRUSSELS - Europe's fast-evolving radiology sector needs common standards in quality, safety, training, and research, or risks seeing imaging procedures become chaotic, expensive, and dangerous, the European Society of Radiology (ESR) warned in Brussels on 4 November.November 4, 2014Molecular ImagingAIPES: Translational research must bridge Valley of DeathBRUSSELS - A senior German molecular imaging specialist is encouraging clinical and basic scientists to communicate better, claiming there is excellent basic research but a lack of translation, and translational research must "cross the Valley of Death."May 13, 2014Molecular ImagingAIPES: Molecular imaging urgently needs evangelistsBRUSSELS - Molecular imaging and nuclear medicine are still widely seen as obscure and unproven specialties, and need established figures to champion them, a leading European nuclear medicine expert told delegates at an Association of Imaging Producers & Equipment Suppliers (AIPES) event.May 12, 2014Clinical NewsEU study charts path to cost-effective cardiac imagingBRUSSELS - Imaging has brought unprecedented insight into cardiovascular disease, but health authorities need smarter and more cost-effective screening strategies to identify high-risk patients, according to a research project presented on Thursday at a special European Parliament hearing in Brussels.November 11, 2013Page 1 of 2Next PageTop StoriesAdvanced VisualizationChatGPT promising as support tool for researchers getting started in AIChatGPT could serve as an academic reference tool for early-career radiologists and researchers.Advanced VisualizationLLMs outperform medical student in solving imaging casesClinical NewsIrish radiologist, 37, dies of cancerDigital X-RaySymphony of radiology: RSNA unveils art winnersIndustry NewsSiemens targets 3.3B patient touchpoints by 2030